Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0000899243-18-020661

Options or other derivatives

  • Chief Scientific Officer acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Erlander Mark Chief Scientific Officer 2018-07-24 Grant or award · Restricted Stock Units +45,000 49,688 D: show line 1 in the form
Loading xslF345X03/doc4.xml…